ATP2B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.745200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.929400E-01
Normal-vs-Stage2
1.437790E-01
Normal-vs-Stage3
1.341950E-01
Normal-vs-Stage4
6.925800E-01
Stage1-vs-Stage2
8.818200E-02
Stage1-vs-Stage3
1.030230E-01
Stage1-vs-Stage4
7.896200E-01
Stage2-vs-Stage3
2.278200E-01
Stage2-vs-Stage4
2.956400E-01
Stage3-vs-Stage4
1.579740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.889600E-01
Normal-vs-AfricanAmerican
8.803000E-01
Normal-vs-Asian
2.348000E-01
Caucasian-vs-AfricanAmerican
1.319950E-01
Caucasian-vs-Asian
8.18920000000833E-05
AfricanAmerican-vs-Asian
4.657700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.271200E-01
Normal-vs-Female
4.545000E-01
Male-vs-Female
6.312600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.050400E-01
Normal-vs-Age(41-60Yrs)
7.234400E-01
Normal-vs-Age(61-80Yrs)
2.510200E-01
Normal-vs-Age(81-100Yrs)
2.002800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.698600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.273200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.999400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.220330E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.641760E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.837200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.425400E-01
Normal-vs-Daily Drinker
3.487600E-01
Normal-vs-Weekly Drinker
7.395600E-02
Normal-vs-Occasional Drinker
9.962000E-01
Normal-vs-Social Drinker
7.663600E-01
Non Drinker-vs-Daily Drinker
9.417600E-01
Non Drinker-vs-Weekly Drinker
8.367600E-01
Non Drinker-vs-Occasional Drinker
4.081800E-02
Non Drinker-vs-Social Drinker
1.126230E-01
Daily Drinker-vs-Weekly Drinker
8.029400E-01
Daily Drinker-vs-Occasional Drinker
4.457600E-02
Daily Drinker-vs-Social Drinker
1.221380E-01
Weekly Drinker-vs-Occasional Drinker
4.096200E-02
Weekly Drinker-vs-Social Drinker
1.105760E-01
Occasional Drinker-vs-Social Drinker
6.257200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.432200E-01
Normal-vs-Grade 2
6.118400E-01
Normal-vs-Grade 3
8.634000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.210100E-02
Grade 1-vs-Grade 3
2.807500E-02
Grade 1-vs-Grade 4
4.432200E-01
Grade 2-vs-Grade 3
6.114000E-01
Grade 2-vs-Grade 4
6.118400E-01
Grade 3-vs-Grade 4
8.634000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.524400E-01
Normal-vs-NonDiabetic
3.314600E-01
Diabetic-vs-NonDiabetic
9.538600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.764800E-01
Normal-vs-NoPancreatitis
3.830200E-01
Pancreatitis-vs-NoPancreatitis
3.759200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.093000E-01
Normal-vs-N1
1.368970E-01
N0-vs-N1
1.673010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.238400E-02
Normal-vs-TP53-NonMutant
7.888000E-01
TP53-Mutant-vs-TP53-NonMutant
6.417700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
